A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction
about
Epoxyeicosatrienoic acids and cardioprotection: the road to translationSoluble epoxide hydrolase: A potential target for metabolic diseasesSoluble epoxide hydrolase: gene structure, expression and deletionPPARγ signaling is required for mediating EETs protective effects in neonatal cardiomyocytes exposed to LPSHigh salt diet modulates vascular response in A2AAR (+/+) and A 2AAR (-/-) mice: role of sEH, PPARγ, and K ATP channels.Inhibition of soluble epoxide hydrolase increases coronary perfusion in miceRoles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts.Aerobic exercise-based rehabilitation affects the activities of progenitor endothelial cells through EETs pathway.The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins.Peroxisome proliferator-activated receptor γ (PPARγ) mediates the protective effect of quercetin against myocardial ischemia-reperfusion injury via suppressing the NF-κB pathway.Inhibition of soluble epoxide hydrolase augments astrocyte release of vascular endothelial growth factor and neuronal recovery after oxygen-glucose deprivation.TPPU enhanced exercise-induced epoxyeicosatrienoic acid concentrations to exert cardioprotection in mice after myocardial infarction.Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction.PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
P2860
Q28241262-0ECC1583-E392-41D0-B9BC-DB11D7D1D1CCQ28270454-8937C320-D557-454A-A16F-B9A76CA41991Q28291292-1743B059-424F-4B0D-97B0-F5E2EE868349Q34488280-B41AC101-3679-4B61-A8D0-930E3675A07AQ35751044-964F8644-025D-47B1-8EA6-5E876D5EFBC6Q35877561-B70335E9-5E0C-4CF4-B01D-24E620FE07F4Q36824230-8C5FA84F-0312-46E4-B0F2-E72CF89136F5Q37213245-A12D5EE8-FFDA-4790-9234-AC1D5AEE0CF8Q37418399-81866697-4C7A-480D-A57C-6E06BB5C1B69Q40633496-F5708D9C-D172-4EFA-9699-423508735ACDQ44069110-180E85DE-D68F-45F0-99F6-28FA79B94CF5Q47266851-54B65EFC-9D31-4BB9-889D-C2534F42E559Q50175494-70A7AE40-4836-463F-B441-C0D6118E8240Q53379079-6BEBB329-E8F2-43A4-8915-3180BDDFA771Q59127320-32543295-AF14-4329-B67A-34DB5DEDB41A
P2860
A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A potent soluble epoxide hydro ...... th acute myocardial infarction
@en
A potent soluble epoxide hydro ...... h acute myocardial infarction.
@nl
type
label
A potent soluble epoxide hydro ...... th acute myocardial infarction
@en
A potent soluble epoxide hydro ...... h acute myocardial infarction.
@nl
prefLabel
A potent soluble epoxide hydro ...... th acute myocardial infarction
@en
A potent soluble epoxide hydro ...... h acute myocardial infarction.
@nl
P2093
P2860
P1476
A potent soluble epoxide hydro ...... th acute myocardial infarction
@en
P2093
Benjamin B Davis
Binaya Wasti
Bruce D Hammock
Christophe Morisseau
Dan-yan Xu
Nipavan Chiamvimonvat
Shui-ping Zhao
Zhe-liang Liu
Zhen-he Wang
P2860
P304
P356
10.1016/J.IJCARD.2012.03.167
P577
2012-04-21T00:00:00Z